OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition
Jiaorong Qu, Xiaoyong Xue, Zhixing WANG, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 1, pp. 31-46
Closed Access | Times Cited: 7
Jiaorong Qu, Xiaoyong Xue, Zhixing WANG, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 1, pp. 31-46
Closed Access | Times Cited: 7
Showing 7 citing articles:
Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
Jiaorong Qu, Le Wang, Yufei Li, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 303-325
Open Access | Times Cited: 11
Jiaorong Qu, Le Wang, Yufei Li, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 303-325
Open Access | Times Cited: 11
The advancement of targeted regulation of hepatic stellate cells using Traditional chinese medicine for the treatment of liver fibrosis
Liang Chen, Jingjing Liu, Meixiu Jiang, et al.
Journal of Ethnopharmacology (2025), pp. 119298-119298
Closed Access
Liang Chen, Jingjing Liu, Meixiu Jiang, et al.
Journal of Ethnopharmacology (2025), pp. 119298-119298
Closed Access
Nets in fibrosis: Bridging innate immunity and tissue remodeling
Xueni Ma, LI Ji-pin, Muyang Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112516-112516
Closed Access | Times Cited: 3
Xueni Ma, LI Ji-pin, Muyang Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112516-112516
Closed Access | Times Cited: 3
Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice
Xiaoyong Xue, Le Wang, Ruiyu Wu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Xiaoyong Xue, Le Wang, Ruiyu Wu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Identification of pivotal genes and crucial pathways in liver fibrosis through WGCNA analysis
Xibing Zhang, Fuli Yang, Lei Han, et al.
Technology and Health Care (2024), pp. 1-18
Closed Access | Times Cited: 1
Xibing Zhang, Fuli Yang, Lei Han, et al.
Technology and Health Care (2024), pp. 1-18
Closed Access | Times Cited: 1
Pharmacokinetic profiling and network pharmacology of honey-fried Licorice: An Integrative workflow to study traditional Chinese medicines (TCMs)
Lifeng Zhao, Xin Yu, Siyang Wu, et al.
Journal of Chromatography B (2024) Vol. 1248, pp. 124353-124353
Closed Access | Times Cited: 1
Lifeng Zhao, Xin Yu, Siyang Wu, et al.
Journal of Chromatography B (2024) Vol. 1248, pp. 124353-124353
Closed Access | Times Cited: 1
Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells
Le Wang, Jiaorong Qu, J Li, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Le Wang, Jiaorong Qu, J Li, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
